E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/19/2020 in the Prospect News Bank Loan Daily.

WD-40 lifts revolver to $150 million, extends to 2025

By Wendy Van Sickle

Columbus, Ohio, March 19 – WD-40 Co. amended and restated its unsecured credit agreement on Monday with Bank of America, NA, increasing revolving commitments to $150 million from $100 million, according to an 8-K filing with the Securities and Exchange Commission.

The amendment also increases the sublimit available for borrowing by WD 40 Co. Ltd., a wholly owned subsidiary of the company for Europe, the Middle East, Africa and India, to $100 million from $50 million.

Also, the amendment modifies certain restrictive covenants. An exception to a prohibition on Investments has been added to allow for intercompany loans or advances from any loan party to subsidiaries that are not loan parties in a total amount of up to $5 million outstanding at any time.

The amended and restated credit agreement includes a new schedule of permitted consolidated capital expenditures to permit the company to make contemplated capital investments in the current and future fiscal years of up to $30.5 million in fiscal year 2020, $19 million in fiscal year 2021, and $15 million for fiscal years 2022, 2023, 2024 and 2025.

The new maturity date is March 16, 2025.

Borrowings bear interest at Libor plus 90 basis points, and there is a commitment fee of 15 bps.

WD-40 is a San Diego maker of lubricants, hand cleaners and household cleaners.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.